NO924395L - Rekombinante menneske-faktor viii derivater - Google Patents

Rekombinante menneske-faktor viii derivater

Info

Publication number
NO924395L
NO924395L NO92924395A NO924395A NO924395L NO 924395 L NO924395 L NO 924395L NO 92924395 A NO92924395 A NO 92924395A NO 924395 A NO924395 A NO 924395A NO 924395 L NO924395 L NO 924395L
Authority
NO
Norway
Prior art keywords
recombinant human
factor viii
human factor
viii derivatives
derivatives
Prior art date
Application number
NO92924395A
Other languages
English (en)
Other versions
NO924395D0 (no
NO308174B1 (no
Inventor
Annelie B Almstedt
Eva Maria Gray
Peter Lind
Catherine Ljung
Helena Inga Sandberg
Jack Spira
Mona Sydow-Baeckman
Helena Wiman
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of NO924395D0 publication Critical patent/NO924395D0/no
Publication of NO924395L publication Critical patent/NO924395L/no
Publication of NO308174B1 publication Critical patent/NO308174B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO924395A 1991-03-15 1992-11-13 DNA-sekvens som koder for et biologisk aktivt rekombinant menneskefaktor VIII-derivat, rekombinant ekspresjonsvektor og vertscelle omfattende DNA-sekvensen, samt fremgangsmÕte for fremstilling av menneskefaktor VIII-derivat NO308174B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9100799A SE468050C (sv) 1991-03-15 1991-03-15 Rekombinant derivat av human faktor VIII
PCT/SE1992/000150 WO1992016557A1 (en) 1991-03-15 1992-03-11 Recombinant human factor viii derivatives

Publications (3)

Publication Number Publication Date
NO924395D0 NO924395D0 (no) 1992-11-13
NO924395L true NO924395L (no) 1993-01-13
NO308174B1 NO308174B1 (no) 2000-08-07

Family

ID=20382191

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924395A NO308174B1 (no) 1991-03-15 1992-11-13 DNA-sekvens som koder for et biologisk aktivt rekombinant menneskefaktor VIII-derivat, rekombinant ekspresjonsvektor og vertscelle omfattende DNA-sekvensen, samt fremgangsmÕte for fremstilling av menneskefaktor VIII-derivat

Country Status (17)

Country Link
EP (1) EP0533862B1 (no)
JP (1) JP2655752B2 (no)
AR (1) AR247590A1 (no)
AT (1) ATE186055T1 (no)
AU (1) AU650730B2 (no)
CA (1) CA2081659C (no)
DE (1) DE69230206T2 (no)
DK (1) DK0533862T3 (no)
ES (1) ES2137182T3 (no)
FI (1) FI107539B (no)
GR (1) GR3032468T3 (no)
IE (1) IE920814A1 (no)
NO (1) NO308174B1 (no)
PT (1) PT100245B (no)
SE (1) SE468050C (no)
WO (1) WO1992016557A1 (no)
ZA (1) ZA921882B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595886A (en) * 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
US6060447A (en) * 1987-05-19 2000-05-09 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
US5364771A (en) * 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US5663060A (en) * 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US5744446A (en) * 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
DK0652962T3 (da) 1992-07-31 1999-08-23 Medeva Holdings Bv Ekspression af rekombinante fusionsproteiner i attenuerede bakterier
SE9300509D0 (sv) * 1993-02-16 1993-02-16 Kabi Pharmacia Ab Peg treatment
SE504074C2 (sv) * 1993-07-05 1996-11-04 Pharmacia Ab Proteinberedning för subkutan, intramuskulär eller intradermal administrering
GB9401787D0 (en) * 1994-01-31 1994-03-23 Medeva Holdings Bv Vaccine compositions
SE9303601D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Improved cell cultivation method and medium
SE9403915D0 (sv) * 1994-11-14 1994-11-14 Annelie Almstedt Process A
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US6197526B1 (en) * 1999-01-04 2001-03-06 Dyax Corp. Polypeptides for binding human factor VIII and fragments of human factor VIII
US7112438B2 (en) 1999-01-04 2006-09-26 Dyax Corp. Binding molecules for human factor VIII and factor VIII-like proteins
EP1038959A1 (en) 1999-03-17 2000-09-27 Aventis Behring Gesellschaft mit beschränkter Haftung Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX
EP1048726B1 (en) * 1999-04-27 2006-07-26 Négrier, Claude Modified factor VIII cDNA
SE9901379D0 (sv) 1999-04-19 1999-04-19 Pharmacia & Upjohn Ab Receptor structures
EP1233064A1 (en) 2001-02-09 2002-08-21 Aventis Behring Gesellschaft mit beschränkter Haftung Modified factor VIII cDNA and its use for the production of factor VIII
EP1283263A1 (en) * 2001-08-08 2003-02-12 Aventis Behring GmbH Modified cDNA for high expression levels of factor VIII and its derivatives
EP1284290A1 (en) * 2001-08-08 2003-02-19 Aventis Behring GmbH Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA
DK2292779T3 (en) 2003-09-30 2017-02-27 Univ Pennsylvania ADENOASS-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME AND APPLICATIONS THEREOF
CN106906241B (zh) 2005-04-07 2020-09-11 宾夕法尼亚大学托管会 增强腺相关病毒载体功能的方法
AU2006233638A1 (en) * 2005-04-14 2006-10-19 Csl Behring Gmbh Modified coagulation Factor VIII with enhanced stability and its derivates
US9315825B2 (en) 2010-03-29 2016-04-19 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
AU2011238708B2 (en) 2010-03-29 2016-02-11 The Trustees Of The University Of Pennsylvania Pharmacologically Induced Transgene Ablation system
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1
JP6224459B2 (ja) 2011-02-17 2017-11-01 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 組織特異性を改変し、ａａｖ９媒介遺伝子導入を改善するための組成物および方法
US9719106B2 (en) 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
CN105017410B (zh) * 2014-04-18 2018-06-08 北京诺思兰德生物技术股份有限公司 一种b区部分缺失型重组人凝血因子ⅷ
ES2763551T3 (es) 2015-04-16 2020-05-29 Univ Emory Promotores y vectores recombinantes para la expresión de proteínas en el hígado y uso de los mismos
SG11201902998SA (en) 2016-10-03 2019-05-30 Daiichi Sankyo Co Ltd PROMOTER OF Hspa5 GENE
WO2022032140A2 (en) 2020-08-07 2022-02-10 Amicus Therapeutics, Inc. Vesicle targeting proteins and uses of same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers
JPS62181786A (ja) * 1985-08-12 1987-08-10 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド 融合蛋白質の製造法
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5451521A (en) * 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins
IL83192A (en) * 1986-07-18 1992-11-15 Gist Brocades Nv Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
NZ219516A (en) * 1987-02-10 1991-02-26 Wellcome Found Fusion proteins of hbcag (hepatitis b virus core antigen)
DE3720246A1 (de) * 1987-06-19 1988-12-29 Behringwerke Ag Faktor viii:c-aehnliches molekuel mit koagulationsaktivitaet
HUT64591A (en) * 1989-11-17 1994-01-28 Novo Nordisk As Protein complexes with viii/c factor activity and process for their production
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
CA2078721A1 (en) * 1991-09-24 1993-03-25 Hiroshi Yonemura Process for preparing human coagulation factor viii protein complex

Also Published As

Publication number Publication date
NO924395D0 (no) 1992-11-13
SE468050B (sv) 1992-10-26
CA2081659A1 (en) 1992-09-16
ZA921882B (en) 1992-11-25
SE9100799D0 (sv) 1991-03-15
AR247590A1 (es) 1995-01-31
SE468050C (sv) 1998-04-27
FI925131A0 (fi) 1992-11-11
FI107539B (fi) 2001-08-31
DE69230206T2 (de) 2000-05-18
DK0533862T3 (da) 2000-01-17
JPH05507420A (ja) 1993-10-28
ES2137182T3 (es) 1999-12-16
PT100245A (pt) 1993-07-30
AU1351392A (en) 1992-10-21
EP0533862B1 (en) 1999-10-27
ATE186055T1 (de) 1999-11-15
PT100245B (pt) 1999-08-31
AU650730B2 (en) 1994-06-30
IE920814A1 (en) 1992-09-23
FI925131A (fi) 1992-11-11
JP2655752B2 (ja) 1997-09-24
WO1992016557A1 (en) 1992-10-01
DE69230206D1 (de) 1999-12-02
CA2081659C (en) 2002-06-25
NO308174B1 (no) 2000-08-07
GR3032468T3 (en) 2000-05-31
SE9100799L (sv) 1992-09-16
EP0533862A1 (en) 1993-03-31

Similar Documents

Publication Publication Date Title
NO924395D0 (no) Rekombinante menneske-faktor viii derivater
FI941398A (fi) Modifioituja peptidijohdannaisia
DE69230727D1 (de) Neuartige peptidderivate
DE69220862T2 (de) Matratze
IT1296786B1 (it) Sedia
FI934588A (fi) Insulinlik vaextfaktor bindande protein haerstammande fraon maenniskoben
NO924040D0 (no) Rullestol
FI920701A (fi) Anordning foer terapeutisk tryckbehandling
KR920020931U (ko) 척추 교정기
NO922488L (no) Rullestol
KR920017579U (ko) 매트리스
DK111891D0 (da) Polypeptid
KR920014657U (ko) 접철 의자
KR930012937U (ko) 절첩 의자
KR930006241U (ko) 환자용 벼개
BR9104880A (pt) Cadeira-maca
KR930008114U (ko) 체위 교정용 의자
KR920016267U (ko) 의 자
ES1019327Y (es) Muneco articulado
NO940377D0 (no) Rullestol
NO913425L (no) Rullestol
NO923332L (no) Madrass
ITTO910157V0 (it) Materasso
BR7100893U (pt) Cadeira dobravel
KR920014658U (ko) 절첩식 의자

Legal Events

Date Code Title Description
MK1K Patent expired